Murray Alzheimer Research and Education Program (MAREP)

Alzheimer's disease and related dementias are a world-wide phenomenon that ignores social class and national boundaries. As age is the greatest risk factor for the development of Alzheimer's disease, more and more individuals will be diagnosed with Alzheimer's disease and related dementias as the population ages.

At the present time there is no known cause or cure for Alzheimer's disease. As the search for an effective treatment continues, it is important that people who have Alzheimer's disease or a related dementia receive the best care possible and are provided with support and opportunities to live meaningful lives.

To implement effective approaches for care of people living with Alzheimer's disease and related dementias, contemporary research findings need to be brought to the attention of all partners in care including people with dementia, family members and friends, health care professionals, and so forth. The converse is true as well in that effective approaches to care need to be brought to the attention of researchers.

The Murray Alzheimer Research and Education Program (MAREP) is an innovative program that adopts a partnership approach and integrates research and educational activities in an effort to improve dementia care practices in Canada and around the world. Although MAREP's research projects are funded by research grants, all of its knowledge translation activities are funded through donations and charitable gifts from individuals and groups: find out how you can support our programs.

More information is available for people living with dementia, care partners, and anyone else affected by dementia in our Innovations Newsletter, published three times per year, the Dementia Weekly News Service, our blog, and the educational tools and training and workshops we offer. 

MAREP Murray Alzheimer Research and Education Program wordmark.

  1. Apr. 17, 2018Protein Alteration Successfully Removes Alzheimer's Risk

    Some individuals have a genetic risk of developing Alzheimer’s disease because instead of having the apoE3 gene, they have a slightly different apoE4 gene. Having one of these altered genes increases risk of developing the disease by half, but having two copies increases it tenfold. In a new study from the Center for Translational Advancement at Gladstone, researchers used human brain cells to test a drug targeting these apoE4 proteins to avoid the common pitfall of drugs working in mice models but failing in humans.

  2. Apr. 17, 2018Ontario Invests $3.3 Billion for Seniors Care and Caregiving Support

    At the Together We Care conference in Etobicoke on April 11, Premier Wynne announced that the Ontario Budget will move forward with funding $3.3 billion toward seniors and caregivers in the next three years. The budget will increase the funding for long-term-care homes to $300 million to increase the number of nurses and personal support workers, and increase care hours. Extending OHIP+ to cover prescription drugs for seniors, creating a Seniors’ Health Home Program, which will provide seniors over 75 years $750 to offset independent living costs.

  3. Apr. 17, 2018Increased Risk for Developing Alzheimer's Disease for Those Who Suffer Epilepsy

    A study out of the University of Eastern Finland has found an unfortunate correlation with anti-epileptic drugs and the development of Alzheimer’s disease (AD) and dementia. Some anti-epileptic drugs are known to cause impairment in cognitive functioning, but this is the first study to attribute prolonged use to the development of AD and dementia. Specifically, the correlation between development of AD and dementia was found in those drugs that had cognitive impairment effects. The researchers found a 20 percent increase of risk for AD and a 60 percent increased risk for dementia.

Read all news
  1. July 25, 2017Canada's National Dementia StrategyMary Beth Wighton Quote

    Last month, Bill C-233, an Act respecting a national strategy for Alzheimer’s disease and other dementias, sponsored by the Honourable Rob Nicholson and Rob Oliphant, was passed. Canada will be the 30th country out of 194 members of the World Health Organization to implement a national dementia plan.

  2. June 6, 2017To the Nurse Who May Care for Me TodayBlog quote

    Hi I am your assignment for today.

    I know I am just one of many but I ask you to please take the time to know me. You see I once was also a nurse. That really doesn't matter as I am a human being. I come with an education and feeling. I am also a wife a mother, a grandmother and more. Please take the time to read my chart as you can gain much knowledge about me before you ever meet me. In it you will find my medical history, this may give you a glimpse of what to expect from me. It will tell you what is being treated now. Know full well that, that may not be my only problem.  

  3. May 2, 2017Ontario Dementia Advisory Group e-newsletter, April 2017

    A Letter from the Chair

    APRIL 2017

    Hello, ODAG Members, Friends, and Supporters.

    The last two months have been very interesting for people living with dementia. It is a time of policy changes, budget allocations and the broadening of the Council of Canadians with Disabilities to formally include people living with dementia.

View all blog posts